Literature DB >> 18164103

Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.

C J Carter1.   

Abstract

The products of the Herpes simplex (HSV-1) genome interact with many Alzheimer's disease susceptibility genes or proteins. These in turn affect those of the virus. For example, HSV-1 binds to heparan sulphate proteoglycans (HSPG2), or alpha-2-macroglobulin (A2M), and enters cells via nectin receptors, which are cleaved by gamma-secretase (APH1B, PSEN1, PSEN2, PEN2, NCSTN). The virus also binds to blood-borne lipoproteins and apolipoprotein E (APOE) is able to modify its infectivity. Viral uptake is cholesterol- and lipid raft-dependent (DHCR24, HMGCR, FDPS, RAFTLIN, SREBF1). The virus is transported to the nucleus via the dynein and kinesin (KNS2) motors associated with the microtubule network (MAPT). Amyloid precursor protein (APP) plays a role in this transport. Nuclear export is mediated via disruption of the nuclear lamina and binding to LMNA. Herpes simplex activates kinases (CDC2 and casein kinase 2) whose substrates include APOE, APP, MAPT, PSEN2, and SREBF1. A viral protein is also able to delete mitochondrial DNA, a situation prevalent in Alzheimer's disease. The virus binds to the host transcription factors transcription factor CP2 (TFCP2) and POU2F1 that control many other genes associated with Alzheimer's disease. Viral latency is controlled by IL6 and IL1B and at different stages of its life cycle the virus can either promote or attenuate apoptosis via Fas and tumor necrosis factor pathways (FAS, TNF, DAPK1, PARP1). Viral evasion strategies include inhibition of the antigen processor TAP2, the production of an Fc immunoglobulin receptor mimic (FCER1G) and inhibition of the viral-activated kinase EIF2AK2. These and other host/viral interactions, targeted to certain Alzheimer's disease susceptibility genes, support the idea that some form of synergy between the pathogen and genetic factors may play a role in the pathology of late-onset Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164103     DOI: 10.1016/j.neuint.2007.11.003

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  27 in total

1.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  GWAS, cytomegalovirus infection, and schizophrenia.

Authors:  Jakob Grove; Anders D Børglum; Brad D Pearce
Journal:  Curr Behav Neurosci Rep       Date:  2014-12-01

3.  Occlusal disharmony increases amyloid-β in the rat hippocampus.

Authors:  D Ekuni; T Tomofuji; K Irie; T Azuma; Y Endo; K Kasuyama; M Morita
Journal:  Neuromolecular Med       Date:  2011-07-13       Impact factor: 3.843

4.  HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Authors:  Julia Elisa Sepulveda-Diaz; Seyedeh Maryam Alavi Naini; Minh Bao Huynh; Mohand Ouidir Ouidja; Constantin Yanicostas; Sandrine Chantepie; Joao Villares; Foudil Lamari; Estelle Jospin; Toin H van Kuppevelt; Ayikoe Guy Mensah-Nyagan; Rita Raisman-Vozari; Nadia Soussi-Yanicostas; Dulce Papy-Garcia
Journal:  Brain       Date:  2015-04-04       Impact factor: 13.501

Review 5.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

6.  Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.

Authors:  Hongguang Chen; Min Wang; Aihong Jiao; Guotai Tang; Wei Zhu; Peng Zou; Tuo Li; Guangqiang Cui; Peiyou Gong
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro.

Authors:  Xiaohong Wu; Li Liang; Liangliang Dong; Zhe Yu; Xiaoqing Fu
Journal:  Mol Biol Rep       Date:  2012-12-18       Impact factor: 2.316

8.  HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Authors:  Elaine L Bearer
Journal:  Future Virol       Date:  2012-09       Impact factor: 1.831

Review 9.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

10.  Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.

Authors:  William A Eimer; Deepak Kumar Vijaya Kumar; Nanda Kumar Navalpur Shanmugam; Alex S Rodriguez; Teryn Mitchell; Kevin J Washicosky; Bence György; Xandra O Breakefield; Rudolph E Tanzi; Robert D Moir
Journal:  Neuron       Date:  2018-07-11       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.